| scholarly article | Q13442814 |
| P356 | DOI | 10.1001/JAMA.1986.03380170076022 |
| P698 | PubMed publication ID | 3639953 |
| P2093 | author name string | M H Stoler | |
| T A Eskin | |||
| L M Angerer | |||
| R C Angerer | |||
| S Benn | |||
| P433 | issue | 17 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | infection of the central nervous system | Q4316437 |
| P304 | page(s) | 2360-2364 | |
| P577 | publication date | 1986-11-01 | |
| P1433 | published in | The Journal of the American Medical Association | Q1470970 |
| P1476 | title | Human T-cell lymphotropic virus type III infection of the central nervous system. A preliminary in situ analysis | |
| P478 | volume | 256 |
| Q28322640 | 1α,25-Dihydroxyvitamin D3 inhibits productive infection of human monocytes by HIV-1 |
| Q36363889 | A family of serine proteases expressed exclusively in myelo-monocytic cells specifically processes the nuclear factor-kappa B subunit p65 in vitro and may impair human immunodeficiency virus replication in these cells |
| Q35872502 | A mechanism of restricted human immunodeficiency virus type 1 expression in human glial cells |
| Q41503684 | A novel assay system for anti-human immunodeficiency virus type 1 (HIV-1) activity using a subclone of a monocytic cell line, U937. |
| Q41651591 | A system for the high efficiency replication of HIV-1 in neural cells and its application to anti-viral evaluation |
| Q70246893 | AIDS dementia |
| Q35664512 | AIDS dementia-related psychosis: is there a window of vulnerability? |
| Q42209697 | AIDS dementia: synthesis and properties of a derivative of 3'-azido-3'-deoxythymidine (AZT) that may become 'locked' in the central nervous system |
| Q42105654 | AIDS subacute encephalitis. Identification of HIV-infected cells. |
| Q37612294 | Acquired immune deficiency syndrome and the developing nervous system |
| Q38708308 | Acquired immune deficiency syndrome in childhood. Neurological aspects |
| Q40603263 | An experimental model system for HIV-1-induced brain injury |
| Q42109932 | Behavioural and morphological evidence for the involvement of glial cell activation in delta opioid receptor function: implications for the development of opioid tolerance. |
| Q72037279 | Bioconvertible screws made of allogenic cortical bone for osteosynthesis following sagittal split ramus osteotomy without postoperative immobilisation |
| Q35788031 | Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis |
| Q45831679 | Brain pathology induced by infection with the human immunodeficiency virus (HIV). A histological, immunocytochemical, and electron microscopical study of 100 autopsy cases |
| Q42172842 | C-C chemokines released by lipopolysaccharide (LPS)-stimulated human macrophages suppress HIV-1 infection in both macrophages and T cells. |
| Q36828096 | CD4-independent infection of human neural cells by human immunodeficiency virus type 1. |
| Q42465505 | Cellular localization of an HIV-1 antigen in subacute AIDS encephalitis using an improved double-labeling immunohistochemical method |
| Q36634412 | Central nervous system-derived cells express a kappa B-binding activity that enhances human immunodeficiency virus type 1 transcription in vitro and facilitates TAR-independent transactivation by Tat. |
| Q36930431 | Chapter 2 Localization of mRNAs by in Situ Hybridization |
| Q69912956 | Cognitive impairment due to AIDS-related complex and its response to psychostimulants |
| Q45769749 | Colocalisation of human immunodeficiency virus and human cytomegalovirus infection in brain autopsy tissue from AIDS patients |
| Q51942900 | Correlation between SIV Tat evolution and AIDS progression in cerebrospinal fluid of morphine-dependent and control macaques infected with SIV and SHIV. |
| Q36232123 | Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease |
| Q48165200 | Cytomembranous inclusions in the brain of a patient with the acquired immunodeficiency syndrome |
| Q70921034 | Deoxyglucose uptake by mouse astrocytes: effects of temperature and retrovirus infection |
| Q35816131 | Effect of 3'-azido-3'-deoxythymidine on human immunodeficiency virus type 1 replication in human fetal brain macrophages |
| Q45833239 | Evidence for human immunodeficiency virus (HIV) infection of the brain in a patient with aplastic anemia |
| Q33628869 | Examination of brains of AIDS cases for human immunodeficiency virus and human cytomegalovirus nucleic acids |
| Q40042302 | Expression of human immunodeficiency virus type 1 in the nervous system of transgenic mice leads to neurological disease |
| Q45846281 | Expression of viral antigens in the central nervous system of visna-infected sheep: an immunohistochemical study on experimental visna induced by virus strains of increased neurovirulence |
| Q37577723 | Galactosyl ceramide or a derivative is an essential component of the neural receptor for human immunodeficiency virus type 1 envelope glycoprotein gp120. |
| Q39273194 | HIV infection of human brain capillary endothelial cells--implications for AIDS dementia |
| Q38248964 | HIV-1 endocytosis in astrocytes: a kiss of death or survival of the fittest? |
| Q35196509 | HIV-1 target cells in the CNS. |
| Q30615171 | HIV-1-associated central nervous system dysfunction |
| Q40309254 | Hematopoietic target cells of anemogenic subgroup C versus nonanemogenic subgroup A feline leukemia virus |
| Q45840910 | Human immunodeficiency virus (HIV) and JC virus in acquired immune deficiency syndrome (AIDS) patients with progressive multifocal leukoencephalopathy |
| Q38266133 | Human immunodeficiency virus (HIV)-induced disease of the central nervous system: pathology and implications for pathogenesis |
| Q24627627 | Human immunodeficiency virus and acquired immunodeficiency syndrome: correlation but not causation |
| Q36656559 | Human immunodeficiency virus infection of human brain capillary endothelial cells occurs via a CD4/galactosylceramide-independent mechanism |
| Q35681073 | Human immunodeficiency virus infection of the brain: pitfalls in evaluating infected/affected cell populations |
| Q36806036 | Human immunodeficiency virus pseudotypes with expanded cellular and species tropism |
| Q33597345 | Human immunodeficiency virus type 1 expression in the central nervous system correlates directly with extent of disease |
| Q33854355 | Human immunodeficiency virus type 1 in spinal cords of acquired immunodeficiency syndrome patients with myelopathy: expression and replication in macrophages |
| Q37047050 | Human immunodeficiency virus type 1 infection of neural xenografts |
| Q36640545 | Human immunodeficiency virus type 1 infection of the brain |
| Q35830741 | Human immunodeficiency virus-infected multinucleated histiocytes in oropharyngeal lymphoid tissues from two asymptomatic patients |
| Q36820658 | Identification of human immunodeficiency virus envelope gene sequences influencing viral entry into CD4-positive HeLa cells, T-leukemia cells, and macrophages |
| Q35856387 | Immunohistochemical localization of human and simian immunodeficiency viral antigens in fixed tissue sections |
| Q35831835 | Immunopathogenic role of T-cell subsets in Borna disease virus-induced progressive encephalitis. |
| Q36680041 | Infection of brain microglial cells by human immunodeficiency virus type 1 is CD4 dependent |
| Q36832031 | Infection of human fetal dorsal root ganglion glial cells with human immunodeficiency virus type 1 involves an entry mechanism independent of the CD4 T4A epitope |
| Q36356836 | Infection of monocyte-derived macrophages with human immunodeficiency virus type 1 (HIV-1). Monocyte-tropic and lymphocyte-tropic strains of HIV-1 show distinctive patterns of replication in a panel of cell types |
| Q71659686 | Inhibition of myelin formation by HIV-1 gp120 in rat cerebral cortex culture |
| Q36055546 | Interferon alpha (IFN)-macrophage interactions in human immunodeficiency virus (HIV) infection: role of IFN in the tempo and progression of HIV disease |
| Q36356182 | Interferons and bacterial lipopolysaccharide protect macrophages from productive infection by human immunodeficiency virus in vitro |
| Q33818097 | Interleukin-16 inhibits human immunodeficiency virus type 1 entry and replication in macrophages and in dendritic cells |
| Q35830811 | Localization of simian immunodeficiency virus in the central nervous system of rhesus monkeys |
| Q44660431 | Macrophage behavior associated with acute and chronic exposure to HIV GP120, morphine and anandamide: endothelial implications |
| Q36685201 | Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism |
| Q36783162 | Macrophage-tropic strains of human immunodeficiency virus type 1 utilize the CD4 receptor |
| Q34963796 | Microglia in human immunodeficiency virus-associated neurodegeneration. |
| Q67944540 | Microglia in the giant cell encephalitis of acquired immune deficiency syndrome: proliferation, infection and fusion |
| Q33932761 | Molecular techniques in the diagnosis of human infectious diseases. |
| Q36790007 | Monocyte-derived macrophages exhibit distinct and more restricted HIV-1 integration site repertoire than CD4(+) T cells |
| Q44257374 | Morphology and distribution of HIV-1 gp41-positive microglia in subacute AIDS encephalitis. Pattern of involvement resembling a multisystem degeneration |
| Q39663214 | Neurological complications in AIDS. |
| Q36989584 | Neurology of AIDS virus infection: a clinical classification |
| Q33785357 | Neuronal death induced by brain-derived human immunodeficiency virus type 1 envelope genes differs between demented and nondemented AIDS patients |
| Q48349275 | Neuropathological studies in the brains of AIDS patients with opportunistic diseases |
| Q59545721 | Neuropathology of the acquired immune deficiency syndrome (AIDS): a report of 135 consecutive autopsy cases from Switzerland |
| Q36334043 | Neurosurgical aspects of human immunodeficiency virus infection. |
| Q36540540 | Oligodendrocyte-specific expression of human immunodeficiency virus type 1 Nef in transgenic mice leads to vacuolar myelopathy and alters oligodendrocyte phenotype in vitro |
| Q42714724 | Pathogenesis of Human Immunodeficiency Virus Type-1 (HIV-1)-Associated Dementia: Role of Voltage-Gated Potassium Channels |
| Q40727055 | Pathogenic mechanisms of neuronal damage in the AIDS dementia complex |
| Q37624156 | Pathology of childhood AIDS. |
| Q68068077 | Persistent inapparent HIV-1 infection of human neuroblastoma cells |
| Q28323864 | Phosphatidylazidothymidine. Mechanism of antiretroviral action in CEM cells |
| Q35699016 | Potentiation of Excitotoxicity in HIV-1 Associated Dementia and the Significance of Glutaminase |
| Q72756380 | Presence of HIV-1 in human parenchymal and non-parenchymal liver cells in vivo |
| Q44532346 | Reduced expression of glutamate transporter EAAT2 and impaired glutamate transport in human primary astrocytes exposed to HIV-1 or gp120. |
| Q28244950 | Regional distribution and partial molecular characterization of CD4-related mRNA in human brain and peripheral tissues |
| Q33449190 | Release of interleukin 1 inhibitory activity (contra-IL-1) by human monocyte-derived macrophages infected with human immunodeficiency virus in vitro and in vivo |
| Q37437788 | Review of the central nervous system cytopathology in human immunodeficiency virus infection |
| Q42104647 | Role of human immunodeficiency virus and cytomegalovirus in AIDS encephalitis. |
| Q24673913 | Role of the basic domain of human immunodeficiency virus type 1 matrix in macrophage infection |
| Q36687739 | Sequences from myeloblastosis-associated virus MAV-2(O) and UR2AV involved in the formation of plaques and the induction of osteopetrosis, anemia, and ataxia |
| Q38488260 | Simultaneous detection of ferritin and HIV-1 in reactive microglia |
| Q36618922 | Temporal patterns of human immunodeficiency virus type 1 transcripts in human fetal astrocytes |
| Q92188718 | The Role of Macrophages in HIV-1 Persistence and Pathogenesis |
| Q38366893 | The immunopathogenesis of HIV infection |
| Q45235165 | The involvement of the cerebral cortex in human immunodeficiency virus encephalopathy: a morphological and immunohistochemical study |
| Q33934512 | The pathogenesis of the neurological complications of HIV-1 infection. |
| Q39592915 | The synthetic immunomodulator murabutide controls human immunodeficiency virus type 1 replication at multiple levels in macrophages and dendritic cells |
| Q45770632 | Vacuolar myelopathy in transgenic mice expressing human immunodeficiency virus type 1 proteins under the regulation of the myelin basic protein gene promoter |
| Q35366667 | Virus receptors: implications for pathogenesis and the design of antiviral agents. |
| Q37015559 | Voltage-gated potassium channel modulation of neurotoxic activity in human immunodeficiency virus type-1(HIV-1)-infected macrophages |
| Q36702174 | Wild-type equine infectious anemia virus replicates in vivo predominantly in tissue macrophages, not in peripheral blood monocytes |
| Q40398144 | gp120 neurotoxicity in primary cortical cultures |
Search more.